Pharmaceutical & Biotech News and Insights

Tracking systems for pharmaceutical companies
Pharmaceutical companies are in the process of creating better tracking systems to monitor patient's use of their prescribed medications. This will not only help to ... 
Read More


AstraZeneca names a new Head of R&D
Sean Bohen has been named head of AstraZeneca's R&D organization. He comes to AstraZeneca from Genentech where he has served as Senior Vice President of ... 
Read More


New website for children with life-threatening allergies
Disney and Mylan, a global generic and specialty pharmaceutical company, have teamed up to create a new website geared toward helping families that have children ... 
Read More


21st Century Cures Act is passed by the US House
The 21st Century Cures Act, which will provide more funding to the FDA and NIH, was approved with a 344 to 77 vote. People who ... 
Read More


AbbVie's Hepatitis C treatment has 100% cure rate
AbbVie unveiled some new data that shows that its Viekira Pak, which combines Vikirax and Exviera, delivered a 100% continued response rate in genotype 1b ... 
Read More


Biotech companies topping Fortune’s fastest-growing pharma list
Fortune 500's fastest-growing pharma list is out and surprisingly only one big pharma company has made the top five. 1) Gilead with a 5-year annual ... 
Read More


Actavis is now Allergan
Following its November buyout, Actavis has announced that it will now be known as Allergan. The company has changed its ticker symbol on the New ... 
Read More


Big Pharma Advertising
The most common mode of advertising for Big Pharma companies remains to be television. With the increased presence of social media, digital and mobile advertising, ... 
Read More


IMS report: Cancer drug spending increases to $100B
New IMS numbers show that global spending on cancer therapies have increased $75 billion in just the last 5 years with a 10.3% increase in ... 
Read More


Mylan rejects Teva’s offer
Mylan has rejected a $40 billion offer from Teva to become the industry's biggest generic drug company. The reasoning behind the rejection was Mylan felt ... 
Read More


« prev - page 1 of 3 - next »